Comments

Alto Neuroscience Stock Price, Quotes and Forecasts

Q: What sector and industry does Alto Neuroscience (ANRO) operate in?

Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

ANRONYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.53

-0.12-4.53%

At close: -

$2.49

-0.04-1.58%

After Hours: 6:11 PM EDT

Q4 2024 Earnings were released on Thu Mar 20th, after the market close

Alto Neuroscience (ANRO) Forecast

News Earnings Alto Neuroscience (ANRO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Alto Neuroscience Stock Price, Quotes and Forecasts | NYSE:ANRO | Benzinga

Explore Alto Neuroscience stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANRO.

Open	$2.68
Close	$2.53
Volume / Avg.	219.54K / 303.93K
Day Range	$2.53 - $2.68
52 Wk Range	2.58 - 18.35
Market Cap	$67.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	32
Short Interest	17.45%
Days to Cover	17.22

Recent News

This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

Nasdaq Down 2%; US Crude Stocks Increase

Avi Kapoor

Neuropsychiatry-Focused Alto Neuroscience's Mid-Stage Depression Trial Disappoints, Analyst Notes Failure Raises Concerns About Platform

Alto Neuroscience's ALTO-100 Phase 2b study for major depressive disorder failed to meet its primary endpoint, but the company plans further data analysis and studies.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.68
Close	$2.53
Volume / Avg.	219.54K / 303.93K
Day Range	$2.53 - $2.68
52 Wk Range	2.58 - 18.35
Market Cap	$67.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	32
Short Interest	17.45%
Days to Cover	17.22

About Alto Neuroscience Inc.

Sector

Health Care

Industry

Pharmaceuticals

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psych...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alto Neuroscience (ANRO) stock?

You can purchase shares of Alto Neuroscience (NYSE:ANRO) through any online brokerage.

View our list of the best stock brokerages

Who are Alto Neuroscience (ANRO) competitors?

Other companies in Alto Neuroscience’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Universe Pharmaceuticals (NASDAQ:UPC), Rani Therapeutics Hldgs (NASDAQ:RANI) and Nutriband (NASDAQ:NTRB).

What is the forecast, or price target, for Alto Neuroscience (ANRO) stock?

Alto Neuroscience has a consensus price target of $19.67.

What is the current price for Alto Neuroscience (ANRO)?

The stock price for Alto Neuroscience (NYSE: ANRO) is $2.49 last updated March 25, 2025 at 6:11 PM EDT.

Does Alto Neuroscience (ANRO) pay a dividend?

There are no upcoming dividends for Alto Neuroscience.

When is Alto Neuroscience (NYSE:ANRO) reporting earnings?

Alto Neuroscience’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Alto Neuroscience (ANRO) going to split?

There is no upcoming split for Alto Neuroscience.

What sector and industry does Alto Neuroscience (ANRO) operate in?

Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.